BOEHRINGER INGELHEIM PHARMA GMBH &CO KG -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:700-800
2019
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:> 1000
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2022-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 32
As coordinator: 0
As participant: 32
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 2.473.985 270.331 1
2021 0 45.736.990 264.207 5
2020 0 85.107.848 252.788 5
2019 0 68.205.073 516.996 9
2018 0 15.942.861 0 2
2017 0 55.675.195 0 6
2016 0 33.556.083 463.820 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA13
PFIZER LIMITED13
BAYER10
JANSSEN PHARMACEUTICA NV10
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN8
ABBVIE INC7
F HOFFMANNLA ROCHE7
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V7
LEIDS UNIVERSITAIR MEDISCH CENTRUM7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
UCB BIOPHARMA7
UNIVERSITY OF DUNDEE7
ASTRAZENECA6
KATHOLIEKE UNIVERSITEIT LEUVEN6
NOVO NORDISK6
SANOFIAVENTIS6
ELI LILLY AND COMPANY LIMITED5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT5
INSTITUT DE RECHERCHES SERVIER5
UNIVERSITAET BERN5
UNIVERSITEIT MAASTRICHT5
ASTRAZENECA AB4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
MEDIZINISCHE UNIVERSITAET WIEN4
UNIVERSITAT WIEN4
UNIVERSITE DU LUXEMBOURG4
UNIVERSITY OF HELSINKI4
ACADEMISCH ZIEKENHUIS GRONINGEN3
ASTELLAS PHARMA EUROPE BV3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER3
JDRF INTERNATIONAL3
LUND UNIVERSITY3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
MERCK SHARP & DOHME CORP3
SANOFIAVENTIS DEUTSCHLAND3
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT3
STICHTING LYGATURE3
STICHTING VUMC3
TAKEDA PHARMACEUTICALS INTERNATIONAL3
TECHNISCHE UNIVERSITAET MUENCHEN3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
AB ENZYMES2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ALLERGAN LIMITED2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BAYER AKTIENGESELLSCHAFT2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CERTARA UK LIMITED2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CONCENTRIS RESEARCH MANAGEMENT2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
KAROLINSKA INSTITUTE2
LEIDEN UNIVERSITY2
LINKOPINGS UNIVERSITET2
LIPOTYPE2
LONZA2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MEDTRONIC INTERNATIONAL TRADING SARL2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE2
ORION OYJ2
OULUN YLIOPISTO2
OWKIN FRANCE2
PSYCHOGENICS INC2
RIJKSUNIVERSITEIT GRONINGEN2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE2
STATENS LEGEMIDDELVERK2
STICHTING BURO ECNP2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TEVA PHARMACEUTICAL INDUSTRIES LIMITED2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF EXETER2
THE UNIVERSITY OF MANCHESTER2
THE UNIVERSITY OF NOTTINGHAM2
THE UNIVERSITY OF TUEBINGEN2
TRANSGENE2
TTOPSTART BV2
UNIVERSITA CATTOLICA DEL SACRO CUORE2
UNIVERSITAET BASEL2
UNIVERSITAET GREIFSWALD2
UNIVERSITAET ZU LUEBECK2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2

Constancy:

Total number of partners: 731
Partner loyalty:
Frequent Partner: (> 2 projects): 249
Rare Partner: 482
Frequent / Rare Partner Ratio: 0.52

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Greener, more sustainable platforms for high-value recombinant protein production greenerRPPparticipant2.473.98515
2021-07-01Real World Handling of Protein Drugs - Exploration, Evaluation and Education RealHOPEparticipant3.139.98425
2021-06-01Psychiatric Ratings using Intermediate Stratified Markers 2 PRISM 2participant3.980.90615
2021-03-01Deconstructing the evolution of metastasis Evometparticipant4.014.43515
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82551
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-06-01Stratification of Obesity Phenotypes to Optimize Future Therapy SOPHIAparticipant8.301.00036
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00023
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18642
2020-01-01INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. INSPIREparticipant4.021.96911
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69430
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-09-01Proton transport and proton-coupled transport PROTONparticipant3.976.97612
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2019-04-01Thrombo-inflammation in cardiovascular disease TICARDIOparticipant3.944.03810
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes Secretersparticipant4.087.42116
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANparticipant3.831.95820
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
2016-03-01Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 VAC2VACparticipant7.850.00023
2016-01-01Big Data in Chemistry BIGCHEMparticipant2.540.14617

Alias institution names:

  • BOEHRINGER INGELHEIM INTERNATIONALGMBH
  • BOEHRINGER INGELHEIM PHARMA GMBH &CO KG
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG
  • BOEHRINGER INGELHEIM VETMEDICA